{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:38:05Z","timestamp":1789497485390,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"VAGLAHS, West Los Angeles Surgical Education Research Center"},{"DOI":"10.13039\/100007185","name":"UCLA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Administration, Washington, D.C","award":["1I01BX000194-01"],"award-info":[{"award-number":["1I01BX000194-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbcan.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T18:08:08Z","timestamp":1469988488000},"page":"141-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Human papillomavirus in oropharyngeal cancer: The changing face of a disease"],"prefix":"10.1016","volume":"1866","author":[{"given":"Jon","family":"Mallen-St Clair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene B.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri S.","family":"Srivatsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2016.07.005_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"I. J. Cancer J. Int. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cncr.20288","article-title":"Annual report to the nation on the status of cancer, 1975\u20132001, with a special feature regarding survival","volume":"101","author":"Jemal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0015","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","article-title":"Head and neck cancer","volume":"345","author":"Forastiere","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1535-6108(04)00090-X","article-title":"Focus on head and neck cancer","volume":"5","author":"Mao","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0025","first-page":"4452","article-title":"A population-based study of therapy and survival for patients with head and neck cancer treated in the community","volume":"118","author":"Ullmann","year":"2012","journal-title":"Cancer-Am Cancer. Soc."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)","volume":"2","author":"Dayyani","year":"2010","journal-title":"Head Neck Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12105-012-0371-6","article-title":"The morphologic profile of HPV-associated head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management","volume":"6","author":"Westra","year":"2012","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/sextrans-2011-050306","article-title":"Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain","volume":"88","author":"Johnson","year":"2012","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ejca.2012.03.014","article-title":"Population-based evidence of increased survival in human papillomavirus-related head and neck cancer","volume":"48","author":"Nygard","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.oraloncology.2013.12.008","article-title":"Clinical significance of head and neck squamous cell cancer biomarkers","volume":"50","author":"Polanska","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ijc.22851","article-title":"Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis","volume":"121","author":"Ragin","year":"2007","journal-title":"Int. J. Cancer. J. Int. du Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.semradonc.2011.12.004","article-title":"Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma","volume":"22","author":"Ang","year":"2012","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.28201","article-title":"Eurogin roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix","volume":"134","author":"Gillison","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0075","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","article-title":"Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis","volume":"48","author":"O'Rorke","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0080","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1078-0432.CCR-14-2481","article-title":"Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes","volume":"21","author":"Keck","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clindermatol.2013.10.006","article-title":"Human papillomavirus-associated diseases","volume":"32","author":"Grce","year":"2014","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidem Biomar"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097232","article-title":"Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and Beta human papillomavirus types","volume":"9","author":"Kwak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0110","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1111\/j.1742-4658.2009.07400.x","article-title":"Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus","volume":"276","author":"Sapp","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0115","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1128\/JVI.01588-15","article-title":"Topography of the human papillomavirus minor capsid protein L2 during vesicular trafficking of infectious entry","volume":"89","author":"DiGiuseppe","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2015.02.021","article-title":"The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane","volume":"481","author":"Day","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","article-title":"L2, the minor capsid protein of papillomavirus","volume":"445","author":"Wang","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0130","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1128\/JVI.00998-07","article-title":"Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus","volume":"81","author":"Selinka","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.04.007","article-title":"Usage of heparan sulfate, integrins, and FAK in HPV16 infection","volume":"403","author":"Abban","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2013.10.034","article-title":"HPV16 infection of HaCaTs is dependent on beta4 integrin, and alpha6 integrin processing","volume":"449","author":"Aksoy","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/v6020893","article-title":"The Tetraspanin CD151 in papillomavirus infection","volume":"6","author":"Scheffer","year":"2014","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1096\/fj.14-251314","article-title":"The thermosensitive TRPV3 channel contributes to rapid wound healing in oral epithelia","volume":"29","author":"Aijima","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0155","doi-asserted-by":"crossref","first-page":"e1002519","DOI":"10.1371\/journal.ppat.1002519","article-title":"Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections","volume":"8","author":"Surviladze","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0160","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JVI.02319-12","article-title":"Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase\/Akt\/mTOR pathway and inhibition of autophagy","volume":"87","author":"Surviladze","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0165","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1128\/JVI.00330-13","article-title":"The evolving field of human papillomavirus receptor research: a review of binding and entry","volume":"87","author":"Raff","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0170","doi-asserted-by":"crossref","first-page":"e43519","DOI":"10.1371\/journal.pone.0043519","article-title":"The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection","volume":"7","author":"Woodham","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0175","doi-asserted-by":"crossref","first-page":"e1002657","DOI":"10.1371\/journal.ppat.1002657","article-title":"Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis","volume":"8","author":"Schelhaas","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2013.11.002","article-title":"Concepts of papillomavirus entry into host cells","volume":"4","author":"Day","year":"2014","journal-title":"Curr. Opin. Virol"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0185","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1128\/JVI.01183-15","article-title":"A dual role for the nonreceptor tyrosine kinase Pyk2 during the intracellular trafficking of human papillomavirus 16","volume":"89","author":"Gottschalk","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0854.2011.01320.x","article-title":"Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17","volume":"13","author":"Marusic","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0195","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3390\/v7052450","article-title":"The role of the DNA damage response throughout the papillomavirus life cycle","volume":"7","author":"McKinney","year":"2015","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0200","article-title":"Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer","author":"Bodelon","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0205","series-title":"HPV and Head and Neck Cancers","first-page":"51","article-title":"The Molecular Biology of HPV-Related Head and Neck Cancer","author":"Maxwell","year":"2015"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0210","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1158\/0008-5472.CAN-11-3085","article-title":"Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein","volume":"72","author":"Jabbar","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0215","article-title":"Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer, GMS current topics in otorhinolaryngology","volume":"11","author":"Wittekindt","year":"2012","journal-title":"Head Neck Surg."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/PAS.0000000000000183","article-title":"Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival","volume":"38","author":"Cai","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0225","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/bjc.2014.42","article-title":"Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review","volume":"110","author":"Gronhoj Larsen","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0230","first-page":"51","article-title":"Significance of p16 in site-specific HPV positive and HPV negative head and neck squamous cell carcinoma","volume":"2","author":"Stephen","year":"2013","journal-title":"Cancer Clin. Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0235","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.oraloncology.2013.09.008","article-title":"The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas","volume":"50","author":"Benson","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.oraloncology.2014.05.004","article-title":"Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas","volume":"50","author":"Westra","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0250","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000650","article-title":"Histologic typing in oropharyngeal squamous cell carcinoma: a 4-year prospective practice study with p16 and high-risk HPV mRNA testing correlation","author":"Gondim","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0260","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hed.20796","article-title":"Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon","volume":"30","author":"Goldenberg","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0265","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ijrobp.2016.03.001","article-title":"High E6 Gene expression predicts for distant metastasis and poor survival in patients with HPV-positive oropharyngeal squamous cell carcinoma","volume":"95","author":"Khwaja","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0270","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1080\/15384047.2015.1056418","article-title":"Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma","volume":"16","author":"Cheng","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa8507","article-title":"Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas","volume":"7","author":"Wang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0280","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0285","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","article-title":"Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas","volume":"33","author":"Huang","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0290","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.2015.64.6448","article-title":"Proposed staging system for patients with HPV-related oropharyngeal cancer based on nasopharyngeal cancer N categories","volume":"34","author":"Dahlstrom","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0295","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/cam4.424","article-title":"Current trends in the etiology and diagnosis of HPV-related head and neck cancers","volume":"4","author":"Chai","year":"2015","journal-title":"Cancer Med.-Us"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0300","first-page":"4171","article-title":"Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma","volume":"6","author":"Capone","year":"2000","journal-title":"Clin. Cancer Res. Off. J. Amer. Assoc. Cancer Res."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0305","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2014.55.1341","article-title":"Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners","volume":"32","author":"D'Souza","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0310","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamaoncol.2015.2524","article-title":"Prognostic implication of persistent human papillomavirus type 16 DNA detection in oral rinses for human papillomavirus-related oropharyngeal carcinoma","volume":"1","author":"Rettig","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0325","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1158\/1535-7163.MCT-14-1015","article-title":"Synergy of radiotherapy and a cancer vaccine for the treatment of HPV-associated head and neck cancer","volume":"14","author":"Mondini","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0330","doi-asserted-by":"crossref","first-page":"e68329","DOI":"10.1371\/journal.pone.0068329","article-title":"Reduced prevalence of oral human papillomavirus (HPV) 4years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica","volume":"8","author":"Herrero","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MOO.0000000000000136","article-title":"Transoral robotic surgery for oropharyngeal squamous cell carcinoma","volume":"23","author":"Schmitt","year":"2015","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surgery"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0340","first-page":"1","article-title":"Oncologic outcomes after transoral robotic surgery : a multi-institutional study","author":"de Almeida","year":"2015","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0345","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.ejca.2014.07.001","article-title":"De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials","volume":"50","author":"Masterson","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0350","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hed.21669","article-title":"Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study","volume":"33","author":"Haughey","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0355","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.18632\/oncotarget.1934","article-title":"An updated overview of HPV-associated head and neck carcinomas","volume":"5","author":"Zaravinos","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","article-title":"Immune modulation in cancer with antibodies","volume":"65","author":"Page","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2015.01.006","article-title":"The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?","volume":"33","author":"Shin","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0370","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2016.04.004","article-title":"Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: review of the literature","volume":"58","author":"Saber","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0375","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.ejca.2013.03.019","article-title":"CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma","volume":"49","author":"Nordfors","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0380","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.18632\/oncotarget.7593","article-title":"CD274\/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity","volume":"7","author":"Straub","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0385","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0390","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-14-1913","article-title":"Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer","volume":"74","author":"Parikh","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0395","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hed.23706","article-title":"Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma","volume":"37","author":"Malm","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12180","article-title":"Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma","volume":"1291","author":"Wolchok","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0405","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-016-9625-1","article-title":"Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives","author":"Ausoni","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0415","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1916-0216-42-36","article-title":"HPV status and second primary tumours in oropharyngeal squamous cell carcinoma","volume":"42","author":"Xu","year":"2013","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0420","doi-asserted-by":"crossref","first-page":"34921","DOI":"10.1074\/jbc.M114.568543","article-title":"p16 protein and gigaxonin are associated with the ubiquitination of NFkappaB in cisplatin-induced senescence of cancer cells","volume":"289","author":"Veena","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0425","series-title":"Interaction of the Host Immune System with Tumor Cells in Human Papillomavirus Associated Diseases","author":"Sauer","year":"2016"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0430","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jamaoto.2015.136","article-title":"Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy","volume":"141","author":"Trosman","year":"2015","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0435","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00705-009-0310-3","article-title":"Insights into the role and function of L2, the minor capsid protein of papillomaviruses","volume":"154","author":"Pereira","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0440","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1015336817836","article-title":"Papillomavirus E1 proteins: form, function, and features","volume":"24","author":"Wilson","year":"2002","journal-title":"Virus Genes"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0445","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1128\/JVI.00345-13","article-title":"CK2 phosphorylation inactivates DNA binding by the papillomavirus E1 and E2 proteins","volume":"87","author":"Schuck","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0450","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1128\/JVI.02029-14","article-title":"Human papillomavirus type 1 E1 lambda E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2","volume":"88","author":"Prescott","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0455","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ejca.2013.12.018","article-title":"Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status","volume":"50","author":"Mirghani","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0460","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3892\/ijo.2013.2105","article-title":"Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6\/E7 zinc finger proteins (review)","volume":"43","author":"Ruttkay-Nedecky","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2016.07.005_bb0465","first-page":"1209","article-title":"Human papillomavirus: clinical manifestations and prevention","volume":"82","author":"Juckett","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbcan.2016.07.005_bb0470","first-page":"453","article-title":"Diseases caused by human papillomaviruses (HPV)","volume":"7","author":"Handisurya","year":"2009","journal-title":"J. Dtsch. Dermatol. Ges."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X16300580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X16300580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T03:56:09Z","timestamp":1536551769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X16300580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0304419X16300580"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2016.07.005","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus in oropharyngeal cancer: The changing face of a disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}